Patient-level interventions to prevent the acquisition of resistant gram-negative bacteria in critically ill

A Zaky1, S B Zeliadt1, M M Treggiari2

  • 1Department of Health Services, VA Puget Sound Health Care System, University of Washington, Seattle, Washington, USA.

Insights

Patient-level interventions significantly reduced multidrug-resistant Gram-negative bacterial (MDR-GNB) colonization and infection in intensive care units. Selective digestive decontamination was a key factor, though further research is needed.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Public Health

Background:

  • Rising incidence of multidrug-resistant Gram-negative bacterial (MDR-GNB) infections in intensive care units (ICUs).
  • Uncertainty regarding the effectiveness of patient-level infection control measures in ICUs.

Purpose of the Study:

  • To systematically review the efficacy of patient-level interventions in preventing MDR-GNB colonization.
  • To assess if these interventions reduce MDR-GNB infection rates in ICUs.

Main Methods:

  • Systematic review of comparative interventional studies from major databases (PubMed, Cochrane, EMBASE, World of Science).
  • Inclusion of studies published in English, Spanish, or French from 2000 to 2013.
  • Analysis of 13 comparative studies (10 randomized, 3 observational) evaluating seven interventions.

Main Results:

  • Overall reduction in MDR-GNB colonization (OR 0.75; 95% CI 0.66-0.85) and infection (OR 0.66; 95% CI 0.59-0.75).
  • Consistent results in pooled analysis of randomized controlled trials.
  • Selective digestive decontamination significantly contributed to the observed reductions.

Conclusions:

  • Patient-level interventions are effective in reducing MDR-GNB colonization and infection in ICUs.
  • Further adequately powered controlled studies are necessary to confirm these findings and explore intervention effects.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
750
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
5.0K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
61
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
158
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.1K